InvestorsHub Logo
Followers 25
Posts 1133
Boards Moderated 0
Alias Born 04/04/2012

Re: TheKobra post# 8270

Wednesday, 11/16/2016 11:34:14 AM

Wednesday, November 16, 2016 11:34:14 AM

Post# of 8473
$5.50 price target. Shares Rally Following Ladenburg Upgrade To Buy, Positive Data

Shares of Repros Therapeutics Inc
RPRX 2.34%
climbed more than 8 percent in Wednesday’s pre-market hours after positive clinical data of Proellex led Ladenburg Thalmann to upgrade shares to Buy, with a $5.50 price target.
Repros announced positive Phase 2b data for both its oral and vaginal delivery trials following two 18-week cycles of treatment with Proellex in uterine fibroids.
Among others, the study met its primary endpoint of induction of amenorrhea for both pooled oral and vaginal delivery compared to placebo. The company plans to submit a request to the FDA before the end of 2016 to discuss the Phase 3 program......

http://www.benzinga.com/analyst-ratings/analyst-color/16/11/8707546/repros-therapeutics-shares-rally-following-ladenburg-upg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RPRX News